San Diego, CA – April 15, 2025 – Antharis Therapeutics, a leading innovator in immuno-oncology, is proud to announce its recognition as the Most Pioneering Biopharmaceutical Company of 2025 – USA by Global Health & Pharma (GHP). This prestigious accolade underscores Antharis’ commitment to advancing next-generation monoclonal antibody therapies aimed at transforming cancer treatment.
The award highlights Antharis’ groundbreaking work in developing a robust pipeline of monoclonal antibodies and antibody-drug conjugates (ADCs) that target aggressive and treatment-resistant cancers. Leveraging a multidisciplinary approach, the company integrates cutting-edge science, AI-driven development tools, and strategic collaborations to accelerate the delivery of life-changing therapies to patients worldwide.
Dr. Raphael Ribeiro-Pinaud, Founder, Chairman, and CEO of Antharis Therapeutics, expressed his gratitude:
“This recognition by GHP is a testament to the relentless dedication of our team and our unwavering mission to bring innovative and effective treatments to patients battling cancer. We are honored to be acknowledged for our pioneering efforts in the biopharmaceutical industry.”
The full feature article detailing Antharis’ innovative approaches and achievements can be found in GHP’s Biotechnology & Life Sciences Awards 2025 issue: https://ghpnews.digital/issues/biotechnology-and-lifesciences-awards-2025/8/.
About Antharis Therapeutics
Founded in 2020, Antharis Therapeutics is a biopharmaceutical company dedicated to the discovery and development of immunotherapeutics to address devastating diseases with limited or unsatisfactory treatment options. With a focus on oncology, Antharis harnesses the power of the immune system to develop cutting-edge therapies, including monoclonal antibodies and ADCs, aiming to improve patient outcomes and quality of life. Headquartered in the Greater San Diego Area, California, Antharis is strategically positioned within one of the world’s prime biotechnology hubs. For more information, please visit www.antharistherapeutics.com.
Media Contact:
Dr. Raphael Ribeiro-Pinaud
Founder, Chairman & CEO
Antharis Therapeutics
Email: contact@antharistherapeutics.com
Phone: 760-481-7609
Address: 1396 Poinsettia Ave, Vista, CA 92081, United States
Follow us on LinkedIn: https://www.linkedin.com/company/antharis-therapeutics
